The AmLaw Litigation Daily highlighted Finnegan attorneys Charles Lipsey, John Livingstone, Jill MacAlpine, David Weingarten, Ryan O’Quinn, Matt Hlinka, and Megan Meyers for their District of Delaware bench trial win on behalf of client AstraZeneca. The ruling protected AstraZeneca’s FARXIGA drug products against generic competition, stating the opposition failed to prove AstraZeneca’s patent claims were invalid due to obviousness.
Award/Ranking
Managing IP Americas Awards 2024: Finnegan Shortlisted for Nine Awards, Including Firm of the Year
March 12, 2024
Commentary
February 29, 2024
Press Release
Finnegan Secures Another Patent Victory for BMW Group in the District of Delaware
February 27, 2024
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.